<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors></authors><secondary-authors><author><style face="normal" font="default" size="100%">Johnson, Jeffrey</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Diabetes and Cancer: ADA Consensus Statement</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2010</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2010-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">36-37</style></pages><abstract><style  face="normal" font="default" size="100%">The association between diabetes and elevated cancer risk is of increasing concern. Some investigators suggest that in addition to the pathology of type 2 diabetes mellitus, the diabetes treatments themselves may play a malignant role. These issues, as highlighted in recent journal and mass media articles as well as in conjunction with the release of a related consensus statement from the American Diabetes Association are discussed.</style></abstract><number><style face="normal" font="default" size="100%">6</style></number><volume><style face="normal" font="default" size="100%">10</style></volume></record></records></xml>